risedronic acid has been researched along with fluorexon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, J; Sato, Y; Shen, CL; Takeda, T; Yeh, JK | 1 |
| Jeong, D; Kim, MY; Lee, K; Lee, KJ; Shin, HI | 1 |
2 other study(ies) available for risedronic acid and fluorexon
| Article | Year |
|---|---|
Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
Topics: Absorptiometry, Photon; Animals; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Disease Models, Animal; Drug Administration Schedule; Etidronic Acid; Female; Femur; Fluoresceins; Image Processing, Computer-Assisted; Ovariectomy; Postoperative Care; Preoperative Care; Rats; Rats, Sprague-Dawley; Risedronic Acid; Tibia | 2006 |
Metabolic activities affect femur and lumbar vertebrae remodeling, and anti-resorptive risedronate disturbs femoral cortical bone remodeling.
Topics: Animals; Biomechanical Phenomena; Bone Density Conservation Agents; Bone Remodeling; Collagen Type I; Cortical Bone; Estrogens; Femur; Fluoresceins; Lumbar Vertebrae; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Osteoporosis; Risedronic Acid | 2021 |